Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 15 December 2009
Vol. 2, Issue 101, p. pc23
[DOI: 10.1126/scisignal.2101pc23]

PODCASTS

Science Signaling Podcast: 15 December 2009

Paul S. Mischel 1 , 2 , 3 and Annalisa M. VanHook 4

1 Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA.
2 Henry Singleton Brain Tumor Program and Jonsson Comprehensive Cancer Center, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA.
3 Molecular and Medical Pharmacology, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA.
4 Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.

Abstract: This is a conversation with Paul Mischel about a Research Article published in the 15 December 2009 issue of Science Signaling.

Citation: P. S. Mischel, A. M. VanHook, Science Signaling Podcast: 15 December 2009. Sci. Signal. 2, pc23 (2009).

Read the Full Text



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882